Ovintiv (NYSE:OVV – Get Free Report) had its target price lifted by Wells Fargo & Company from $42.00 to $54.00 in a report released on Thursday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target points to a potential downside of 5.32% from the stock’s previous close.
Several other research analysts have also issued reports on the stock. Zacks Research upgraded shares of Ovintiv from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 3rd. Stephens upgraded Ovintiv to a “hold” rating in a research report on Tuesday, February 3rd. William Blair assumed coverage on Ovintiv in a research note on Wednesday, November 26th. They set an “outperform” rating and a $50.00 price objective for the company. National Bank Financial lifted their target price on Ovintiv from $56.00 to $58.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $55.00 target price on shares of Ovintiv in a research report on Thursday, February 19th. Fourteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $56.17.
Get Our Latest Stock Analysis on OVV
Ovintiv Price Performance
Ovintiv (NYSE:OVV – Get Free Report) last announced its quarterly earnings data on Monday, February 23rd. The company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.41. Ovintiv had a net margin of 13.94% and a return on equity of 12.00%. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.89 billion. During the same quarter in the previous year, the company posted ($0.23) EPS. As a group, analysts expect that Ovintiv will post 5.59 earnings per share for the current fiscal year.
Insider Buying and Selling at Ovintiv
In other Ovintiv news, EVP Meghan Nicole Eilers sold 11,582 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $54.78, for a total transaction of $634,461.96. Following the transaction, the executive vice president directly owned 54,092 shares of the company’s stock, valued at $2,963,159.76. This represents a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Howard John Mayson sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $52.39, for a total value of $261,950.00. Following the transaction, the director owned 45,780 shares in the company, valued at approximately $2,398,414.20. This trade represents a 9.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.70% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. McIlrath & Eck LLC acquired a new stake in Ovintiv in the 3rd quarter worth approximately $31,000. HM Payson & Co. bought a new stake in Ovintiv during the third quarter worth approximately $36,000. Foster Dykema Cabot & Partners LLC acquired a new position in Ovintiv during the third quarter valued at approximately $36,000. Quent Capital LLC acquired a new position in Ovintiv during the third quarter valued at approximately $37,000. Finally, Flagship Harbor Advisors LLC bought a new position in shares of Ovintiv in the fourth quarter valued at approximately $38,000. Institutional investors and hedge funds own 83.81% of the company’s stock.
Key Ovintiv News
Here are the key news stories impacting Ovintiv this week:
- Positive Sentiment: Scotiabank raised its price target from $58 to $65 and put Ovintiv at “sector outperform,” implying meaningful upside and boosting investor enthusiasm. Scotiabank Raises PT to $65
- Positive Sentiment: TD Cowen raised its price target to $60, another analyst lift that helps bid the stock higher after recent strong quarterly results. TD Cowen Boosts PT to $60
- Positive Sentiment: An analyst upgrade pushed Ovintiv to a new 12‑month high, signaling renewed institutional interest. Ovintiv Sets New 12-Month High
- Positive Sentiment: Forbes included Ovintiv on a list of “best undervalued stocks,” which can attract value-seeking investors and retail flows. Forbes Undervalued Stocks
- Neutral Sentiment: Wells Fargo raised its target from $42 to $54 but kept an “equal weight” rating; the new target is slightly below current levels, signaling limited near-term upside despite a higher forecast. Wells Fargo Raises PT to $54
- Neutral Sentiment: Market/sector updates noted by Kalkine reflect typical energy‑sector trading activity rather than company‑specific news, so impacts are likely muted. Energy Sector Update
- Neutral Sentiment: Zacks published commentary on Ovintiv’s Q1 results — the Q1 EPS beat is supportive, but the piece is more analysis than a catalyst. Zacks Weighs In on Q1
- Negative Sentiment: Zacks Research (different note) reports brokers have reduced earnings estimates for Ovintiv, which could cap valuation multiples if revisions continue. Brokers Reduce Earnings Estimates
Ovintiv Company Profile
Ovintiv Inc is a North American energy company focused on the exploration, development and production of oil, natural gas and natural gas liquids. Formerly known as Encana Corporation, the company rebranded as Ovintiv in January 2020 and established its headquarters in Denver, Colorado. Ovintiv’s upstream portfolio spans multiple unconventional resource plays, reflecting a strategy centered on high-return projects and disciplined capital allocation.
The company’s core business activities include the acquisition and development of acreage in major shale basins across the United States and Canada.
Featured Stories
Receive News & Ratings for Ovintiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ovintiv and related companies with MarketBeat.com's FREE daily email newsletter.
